文献速递抗栓抗凝管理药物相互作用药物不良反应与药物警戒

将直接口服抗凝药综合管理纳入抗凝门诊

Incorporating Comprehensive Management of Direct Oral Anticoagulants into Anticoagulation Clinics.
PubMed 文献 · Pharmacotherapy · 2017-09-06

本综述阐述抗凝门诊从华法林模式向纳入直接口服抗凝药(DOAC)综合管理的实践模型。文章描述DOAC管理中的处方与剂量、依从性、药物相互作用及高费用等挑战,并提出将DOAC管理服务整合进传统抗凝门诊的模式。

要点

  • DOAC虽无需血药监测,但仍需持续管理处方剂量、依从性及药物相互作用。
  • 传统华法林抗凝门诊模型可扩展为涵盖DOAC的综合抗凝管理中心。
  • DOAC管理面临高药物费用等新挑战,需专门服务模式支持。

核心结论

  • 需要建立综合抗凝中心来管理和监测包括DOAC在内的所有口服抗凝药。

研究设计与样本

  • 本文为综述,描述DOAC管理中的挑战与机遇,并提出将DOAC管理服务整合进传统抗凝门诊的实践模型。

主要发现

  • 抗凝门诊传统上基于华法林模型,因需频繁血药监测、药物相互作用、饮食考虑及围操作期管理。
  • 华法林抗凝门诊模型已证明可改善抗凝控制并减少出血并发症。
  • DOAC虽因无需血药监测和饮食考虑而带来便利,但存在处方与剂量问题、药物依从性、药物相互作用及高药物费用等新挑战,需要持续监测。

临床怎么用

  • 将DOAC管理服务整合进传统抗凝门诊,以综合管理所有口服抗凝药。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Anticoagulation clinics emerged as a means to optimize warfarin effectiveness and minimize bleeding risks. Anticoagulation clinics have traditionally been warfarin-based models due to the need for frequent blood-level monitoring, drug interactions, dietary considerations, and periprocedural management with warfarin. These models have demonstrated improved anticoagulation control and reduced bleeding complications for patients taking warfarin. Direct oral anticoagulants (DOACs) emerged with the perception of improved convenience due to the lack of blood-level monitoring and lack of dietary considerations. Despite the advantages of DOAC therapy, new challenges exist with their management, warranting ongoing monitoring. Such challenges include prescribing and dosing issues, drug adherence, drug interactions, and high drug cost. Comprehensive anticoagulation centers are needed to manage and monitor all oral anticoagulants including DOACs. The objectives of this review are to describe the challenges and opportunities that exist in the management of DOACs and to describe a practice model that integrates a DOAC management service into the traditional anticoagulation clinic.

来源:Pharmacotherapy,查看原文。版权归原作者所有。

引用

  1. Mohammad I, Korkis B, Garwood CL, et al. Incorporating Comprehensive Management of Direct Oral Anticoagulants into Anticoagulation Clinics. Pharmacotherapy. 2017. PMID: 28730690. doi:10.1002/phar.1991

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。